The Genetics of Cardiovascular Diseases Consortium, the first of this kind in Russia, was unveiled at HSE University at Cardiogenetics and Bioinformatics: 2021 Realities, an interdisciplinary forum. The consortium aims to compile a centralized and complete catalogue of the Russian population’s genomic mutations..
Research has shown that various demographics have their own genetic mutations. The Genetics of Cardiovascular Diseases Consortium aligns the effort of various research groups and institutions to investigate the genetics of cardiovascular diseases (CVDs), which have been among the leading causes of death around the world for some time. The consortium’s activities are aimed at facilitating the choice of therapy that would take into account individual mutations and better personalize treatment.
Creating a centralized and complete catalogue of the Russian population’s genomic mutations is necessary for improving diagnostics and treatment of CVDs. The goal of the Consortium is to collect a nationwide catalogue of these mutations, develop and apply it in medical practice, and in the future, to create special user services for the process.
Maria Poptsova, Head of the International Laboratory of Bioinformatics at the HSE Faculty of Computer Science Big Data and Information Retrieval School
The last two decades have shown that genetic foundation is important and, in some cases, even critical for making treatment decisions: the same treatment may bring benefit to one patient, harm another patient, and do nothing for yet another patient. Experienced multidisciplinary teams are needed to choose the proper therapy for a specific person that would take into account their genetics. The consortium brings such experts together and offers a platform for creating new teams in cardiogenetics
The list of consortium participants is available here.